{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:12:27Z","timestamp":1786482747435,"version":"build-2736575974"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117384","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T06:26:13Z","timestamp":1759472773000},"page":"117384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P4","title":["Tissue-specific regulation of NO-GC isoforms in the cardiovascular system"],"prefix":"10.1016","volume":"242","author":[{"given":"Jan","family":"Giesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Menges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf A.","family":"Benndorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117384_b0005","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1152\/physrev.00022.2015","article-title":"Molecular physiology of membrane guanylyl cyclase receptors","volume":"96","author":"Kuhn","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2025.117384_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.niox.2018.11.004","article-title":"Neuronal nitric oxide synthase (nNOS) splice variant function: insights into nitric oxide signaling from skeletal muscle","volume":"82","author":"Balke","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2025.117384_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2025.117384_b0020","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/01.CIR.0000145608.80855.BC","article-title":"Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction","volume":"110","author":"Massion","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.117384_b0025","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/0024-3205(95)02191-K","article-title":"Expression of constitutive endothelial nitric oxide synthase in human blood platelets","volume":"57","author":"Sase","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0030","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1523\/JNEUROSCI.2259-06.2006","article-title":"Tonic and phasic nitric oxide signals in hippocampal long-term potentiation","volume":"26","author":"Hopper","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117384_b0035","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1073\/pnas.91.10.4214","article-title":"Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity","volume":"91","author":"Dinerman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0040","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.93.23.13176","article-title":"Elevated blood pressures in mice lacking endothelial nitric oxide synthase","volume":"93","author":"Shesely","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/377239a0","article-title":"Hypertension in mice lacking the gene for endothelial nitric oxide synthase","volume":"377","author":"Huang","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117384_b0050","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI1699","article-title":"Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling","volume":"101","author":"Rudic","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117384_b0055","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1172\/JCI1560","article-title":"Nitric oxide synthase modulates angiogenesis in response to tissue ischemia","volume":"101","author":"Murohara","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117384_b0060","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1172\/JCI81067","article-title":"P2Y2 and Gq\/G11 control blood pressure by mediating endothelial mechanotransduction","volume":"125","author":"Wang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117384_b0065","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145734","article-title":"Protein kinase N2 mediates flow-induced endothelial NOS activation and vascular tone regulation","volume":"131","author":"Jin","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"829\u201337","key":"10.1016\/j.bcp.2025.117384_b0070","first-page":"837a","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2025.117384_b0075","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1021\/bi00184a036","article-title":"Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states","volume":"33","author":"Stone","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2025.117384_b0080","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1038\/sj.emboj.7600422","article-title":"NO activation of guanylyl cyclase","volume":"23","author":"Russwurm","year":"2004","journal-title":"EMBO J."},{"issue":"Pt 1","key":"10.1016\/j.bcp.2025.117384_b0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/bj3350125","article-title":"Functional properties of a naturally occurring isoform of soluble guanylyl cyclase","volume":"335","author":"Russwurm","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2025.117384_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-5793(90)80489-6","article-title":"Expression of soluble guanylyl cyclase catalytic activity requires two enzyme subunits","volume":"272","author":"Harteneck","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2025.117384_b0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(91)80871-Y","article-title":"Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase interchangeability of the alpha-subunits of the enzyme","volume":"292","author":"Harteneck","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2025.117384_b0100","doi-asserted-by":"crossref","first-page":"21109","DOI":"10.1074\/jbc.270.36.21109","article-title":"A variant of the alpha 2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein","volume":"270","author":"Behrends","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2017.11.010","article-title":"BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: evidence for stable insertion of activator drugs","volume":"147","author":"S\u00f6mmer","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0110","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.bcp.2010.08.007","article-title":"Direct fusion of subunits of heterodimeric nitric oxide sensitive guanylyl cyclase leads to functional enzymes with preserved biochemical properties: evidence for isoform specific activation by ciguates","volume":"80","author":"Haase","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177557","article-title":"Discovery of the first isoform-specific sGC activator: selective activation of GC-1 by runcaciguat","volume":"996","author":"Stomberg","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0898-6568(02)00078-5","article-title":"Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain","volume":"15","author":"Mergia","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2025.117384_b0125","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1460-9568.2011.07654.x","article-title":"Presynaptic nitric oxide\/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus","volume":"33","author":"Neitz","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117384_b0130","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/cercor\/bht048","article-title":"Postsynaptic NO\/cGMP increases NMDA receptor currents via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus","volume":"24","author":"Neitz","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bcp.2025.117384_b0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bcp.2016.10.008","article-title":"Heterodimerization with the \u03b21 subunit directs the \u03b12 subunit of nitric oxide-sensitive guanylyl cyclase to calcium-insensitive cell-cell contacts in HEK293 cells: interaction with Lin7a","volume":"122","author":"Hochheiser","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ejn.15564","article-title":"Hippocampal AMPA- and NMDA-induced cGMP signals are mainly generated by NO-GC2 and are under tight control by PDEs 1 and 2","volume":"55","author":"Giesen","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117384_b0145","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuint.2004.03.011","article-title":"Nitric oxide-sensitive guanylyl cyclase: structure and regulation","volume":"45","author":"Koesling","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bcp.2025.117384_b0150","article-title":"cGMP Signaling and Vascular Smooth Muscle Cell Plasticity","volume":"5","author":"Lehners","year":"2018","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.bcp.2025.117384_b0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/164_2018_197","article-title":"Soluble guanylate cyclase stimulators and activators","volume":"264","author":"Sandner","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/164_2016_100","article-title":"Novel sGC stimulators and sGC activators for the treatment of heart failure","volume":"243","author":"Breitenstein","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R400035200","article-title":"The biology of cyclic GMP-dependent protein kinases","volume":"280","author":"Hofmann","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00015.2005","article-title":"Function of cGMP-dependent protein kinases as revealed by gene deletion","volume":"86","author":"Hofmann","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2025.117384_b0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/pro.4008","article-title":"Cyclic nucleotide selectivity of protein kinase G isozymes","volume":"30","author":"Kim","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0180","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2025.117384_b0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-540-68964-5_7","article-title":"Cyclic nucleotide-gated channels","author":"Biel","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0190","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nrd3576","article-title":"Exploring HCN channels as novel drug targets","volume":"10","author":"Postea","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117384_b0195","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.7150\/ijbs.49871","article-title":"Role of smooth muscle cells in Cardiovascular Disease","volume":"16","author":"Zhuge","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0200","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI27657","article-title":"Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system","volume":"116","author":"Mergia","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117384_b0205","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1073\/pnas.0609778104","article-title":"Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase","volume":"104","author":"Friebe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0210","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1113\/jphysiol.2014.273540","article-title":"Dominant role of interstitial cells of Cajal in nitrergic relaxation of murine lower oesophageal sphincter","volume":"593","author":"Groneberg","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2025.117384_b0215","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1113\/JP270511","article-title":"Nitrergic signalling via interstitial cells of Cajal regulates motor activity in murine colon","volume":"593","author":"Lies","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2025.117384_b0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.115.227728","article-title":"Angiotensin II-induced hypertension is attenuated by reduction of sympathetic output in NO-sensitive Guanylyl Cyclase 1 knockout mice","volume":"356","author":"Broekmans","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117384_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19040967","article-title":"Impact of the NO-sensitive Guanylyl Cyclase 1 and 2 on renal blood flow and systemic blood pressure in mice","volume":"19","author":"Mergia","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080674","article-title":"Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension","volume":"8","author":"Stegbauer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117384_b0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/cvr\/cvn068","article-title":"Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice","volume":"79","author":"Buys","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0240","doi-asserted-by":"crossref","first-page":"H654","DOI":"10.1152\/ajpheart.00367.2009","article-title":"sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models","volume":"297","author":"Buys","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2025.117384_b0245","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1172\/JCI60119","article-title":"Genetic modifiers of hypertension in soluble guanylate cyclase \u03b11-deficient mice","volume":"122","author":"Buys","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117384_b0250","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCULATIONAHA.109.890962","article-title":"Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice","volume":"121","author":"Groneberg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.117384_b0255","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.286.5444.1583","article-title":"Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha","volume":"286","author":"Surks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117384_b0260","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/35004606","article-title":"Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta","volume":"404","author":"Schlossmann","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117384_b0265","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/emboj\/17.11.3045","article-title":"Defective smooth muscle regulation in cGMP kinase I-deficient mice","volume":"17","author":"Pfeifer","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.117384_b0270","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.bjp.0703061","article-title":"Impaired relaxation of stomach smooth muscle in mice lacking cyclic GMP-dependent protein kinase I","volume":"129","author":"Ny","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0275","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/HYPERTENSIONAHA.110.164327","article-title":"Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1","volume":"57","author":"Giachini","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2025.117384_b0280","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/bph.13868","article-title":"Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats","volume":"174","author":"Laursen","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0285","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0014-2999(90)94182-W","article-title":"Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle","volume":"191","author":"Maurice","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0290","first-page":"663","article-title":"Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells","volume":"61","author":"Busch","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0295","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00424-017-2106-8","article-title":"Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase","volume":"470","author":"D\u00fcnnes","year":"2018","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2025.117384_b0300","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCULATIONAHA.119.043061","article-title":"Phosphodiesterase 3A and arterial hypertension","volume":"142","author":"Ercu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.117384_b0305","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/HYPERTENSIONAHA.122.19433","article-title":"Mutations in phosphodiesterase 3A (PDE3A) cause hypertension without cardiac damage","volume":"80","author":"Ercu","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2025.117384_b0310","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/CIRCULATIONAHA.122.060210","article-title":"Mutant phosphodiesterase 3A protects from hypertension-induced cardiac damage","author":"Ercu","year":"2022","journal-title":"Circulation 146"},{"key":"10.1016\/j.bcp.2025.117384_b0315","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1464-410X.1996.10220.x","article-title":"Sildenafil, a novel effective oral therapy for male erectile dysfunction","volume":"78","author":"Boolell","year":"1996","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.bcp.2025.117384_b0320","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/ATVBAHA.115.306133","article-title":"Cyclic GMP in vascular relaxation: export is of similar importance as degradation","volume":"35","author":"Krawutschke","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0325","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.120.15856","article-title":"Nitric oxide-cGMP signaling in hypertension: current and future options for pharmacotherapy","volume":"76","author":"Ataei Ataabadi","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2025.117384_b0330","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jvs.2009.08.045","article-title":"Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia in mice","volume":"51","author":"Park","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.bcp.2025.117384_b0335","first-page":"222","article-title":"Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice","volume":"42","author":"Brooks","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0340","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10456-015-9463-8","article-title":"Cell-specific impact of nitric oxide-dependent guanylyl cyclase on arteriogenesis and angiogenesis in mice","volume":"18","author":"Bettaga","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bcp.2025.117384_b0345","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardiores.2004.08.020","article-title":"Structural and functional characterisation of cardiac fibroblasts","volume":"65","author":"Camelliti","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0350","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","author":"Fan","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bcp.2025.117384_b0355","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2025.117384_b0360","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0365","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s44161-022-00043-7","article-title":"Fibroblasts orchestrate cellular crosstalk in the heart through the ECM","volume":"1","author":"Bowers","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0370","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.bpj.2018.03.018","article-title":"Nuclear transport and accumulation of Smad proteins studied by single-molecule microscopy","volume":"114","author":"Li","year":"2018","journal-title":"Biophys. J ."},{"key":"10.1016\/j.bcp.2025.117384_b0375","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCRESAHA.107.157677","article-title":"Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts","volume":"102","author":"Li","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0380","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1210\/me.2011-1009","article-title":"cGMP inhibits TGF-beta signaling by sequestering Smad3 with cytosolic beta2-tubulin in pulmonary artery smooth muscle cells","volume":"25","author":"Gong","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2025.117384_b0385","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/annrheumdis-2013-204508","article-title":"Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGF\u03b2 signalling","volume":"74","author":"Beyer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2025.117384_b0390","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/2211-5463.12202","article-title":"Inhibition of the TGF\u03b2 signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis","volume":"7","author":"Schinner","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bcp.2025.117384_b0395","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1345402","article-title":"Combined activation of guanylate cyclase and cyclic AMP in lung fibroblasts as a novel therapeutic concept for lung fibrosis","volume":"2019","author":"Lambers","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2025.117384_b0400","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1111\/bph.14835","article-title":"Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts","volume":"176","author":"Menges","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0405","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00395-011-0228-2","article-title":"Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart","volume":"106","author":"Miller","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bcp.2025.117384_b0410","doi-asserted-by":"crossref","first-page":"H1246","DOI":"10.1152\/ajpheart.00852.2013","article-title":"PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways","volume":"306","author":"Vettel","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2025.117384_b0415","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11684-014-0378-3","article-title":"Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis through inhibition of transforming growth factor \u03b2-induced Smad signaling","volume":"8","author":"Gong","year":"2014","journal-title":"Front. Med."},{"key":"10.1016\/j.bcp.2025.117384_b0420","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s42003-023-04880-5","article-title":"It takes two to tango: cardiac fibroblast-derived NO-induced cGMP enters cardiac myocytes and increases cAMP by inhibiting PDE3","volume":"6","author":"Menges","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0425","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112436","article-title":"Angiotensin II-induced cardiovascular fibrosis is attenuated by NO-sensitive Guanylyl Cyclase1","volume":"9","author":"Broekmans","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2025.117384_b0430","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2021.03.020","article-title":"Novel perspectives on redox signaling in red blood cells and platelets in cardiovascular disease","volume":"168","author":"Mahdi","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2025.117384_b0435","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1160\/TH11-05-0319","article-title":"Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase","volume":"106","author":"Rukoyatkina","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcp.2025.117384_b0440","doi-asserted-by":"crossref","unstructured":"C. Mauersberger, H.B. Sager, J. Wobst, T. an Dang, L. Lambrecht, S. Koplev, M. Stroth, N. Bettaga, J. Schlossmann, F. Wunder, A. Friebe, J.L.M. Bj\u00f6rkegren, L. Dietz, S.L. Maas, E.P.C. van der Vorst, P. Sandner, O. Soehnlein, H. Schunkert, T. Kessler, Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation, Nat. Cardiovasc. Res. 1 (2022) 1174\u20131186. https:\/\/doi.org\/10.1038\/s44161-022-00175-w.","DOI":"10.1038\/s44161-022-00175-w"},{"key":"10.1016\/j.bcp.2025.117384_b0445","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.redox.2017.08.020","article-title":"Identification of a soluble guanylate cyclase in RBCs: preserved activity in patients with coronary artery disease","volume":"14","author":"Cortese-Krott","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0450","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167693","article-title":"Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP","volume":"133","author":"Yang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117384_b0455","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.redox.2013.12.031","article-title":"Nitrosopersulfide (SSNO(-)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide","volume":"2","author":"Cortese-Krott","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0460","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/CIRCRESAHA.116.308139","article-title":"Recounting cardiac cellular composition","volume":"118","author":"Zhou","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0465","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of Cell Generation and turnover in the Human Heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117384_b0470","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004242","article-title":"Calcium signaling in cardiac myocytes","volume":"3","author":"Fearnley","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0475","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.RES.79.3.363","article-title":"Nitric oxide and cardiac function","volume":"79","author":"Kelly","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0480","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1161\/01.RES.0000064585.95749.6D","article-title":"Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling","volume":"92","author":"Sears","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044481","article-title":"The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy","volume":"7","author":"Irvine","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117384_b0490","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/CIRCRESAHA.114.302437","article-title":"Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes","volume":"114","author":"G\u00f6tz","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0495","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.RES.0000200178.34179.93","article-title":"Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO\/cGMP-dependent pathway","volume":"98","author":"Mongillo","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0500","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2025.117384_b0505","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14336\/AD.2022.0523","article-title":"The NO-cGMP-PKG axis in HFpEF: from pathological mechanisms to potential therapies","volume":"14","author":"Cai","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.bcp.2025.117384_b0510","doi-asserted-by":"crossref","unstructured":"S. Schobesberger, P.T. Wright, C. Poulet, J.L. Sanchez Alonso Mardones, C. Mansfield, A. Friebe, S.E. Harding, J.-L. Balligand, V.O. Nikolaev, J. Gorelik, \u03b23-Adrenoceptor redistribution impairs NO\/cGMP\/PDE2 signalling in failing cardiomyocytes, Elife 9 (2020). https:\/\/doi.org\/10.7554\/eLife.52221.","DOI":"10.7554\/eLife.52221"},{"key":"10.1016\/j.bcp.2025.117384_b0515","doi-asserted-by":"crossref","first-page":"E7428","DOI":"10.1073\/pnas.1800996115","article-title":"Phosphodiesterase 2 inhibition preferentially promotes NO\/guanylyl cyclase\/cGMP signaling to reverse the development of heart failure","volume":"115","author":"Baliga","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0520","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/cvr\/cvy039","article-title":"Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase","volume":"114","author":"Frankenreiter","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0525","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/ars.2015.6542","article-title":"Decreased soluble guanylate cyclase contributes to cardiac dysfunction induced by chronic doxorubicin treatment in mice","volume":"26","author":"Vandenwijngaert","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2025.117384_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102179","article-title":"Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia","volume":"48","author":"Bork","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0535","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117384_b0540","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117384_b0545","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with Heart failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117384_b0550","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CRD.0b013e3181fc1c10","article-title":"Soluble guanylate cyclase activation with cinaciguat: a new approach to the treatment of decompensated heart failure","volume":"19","author":"Hingorany","year":"2011","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.bcp.2025.117384_b0555","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/mol.117.109918","article-title":"Irreversible activation and stabilization of soluble guanylate cyclase by the protoporphyrin IX mimetic cinaciguat","volume":"93","author":"Kollau","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0560","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12931-022-02189-1","article-title":"Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC","volume":"23","author":"Becker-Pelster","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0565","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713226","article-title":"The sGC activator runcaciguat has kidney protective effects and prevents a decline of kidney function in ZSF1 Rats","volume":"24","author":"Kraehling","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0570","doi-asserted-by":"crossref","first-page":"20027","DOI":"10.1074\/jbc.M801223200","article-title":"Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor","volume":"283","author":"Marro","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0575","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.devcel.2011.06.022","article-title":"Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase","volume":"21","author":"Chang","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2025.117384_b0580","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","article-title":"FOXO transcription factors as therapeutic targets in human diseases","volume":"43","author":"Orea-Soufi","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0585","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1124\/mol.118.115386","article-title":"Antagonism of forkhead box subclass O transcription factors elicits loss of soluble Guanylyl Cyclase expression","volume":"95","author":"Galley","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0590","doi-asserted-by":"crossref","first-page":"H417","DOI":"10.1152\/ajpheart.00551.2021","article-title":"FoxO4 controls sGC\u03b2 transcription in vascular smooth muscle","volume":"322","author":"Galley","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2025.117384_b0595","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/emboj\/17.12.3448","article-title":"Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs","volume":"17","author":"Fan","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.117384_b0600","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/nar\/28.14.2695","article-title":"The identification of an endonuclease that cleaves within an HuR binding site in mRNA","volume":"28","author":"Zhao","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117384_b0605","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1074\/jbc.M206453200","article-title":"Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta","volume":"278","author":"Kloss","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0610","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1124\/mol.65.6.1440","article-title":"Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR","volume":"65","author":"Kl\u00f6ss","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0615","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/01.HYP.0000165674.58470.8f","article-title":"Human-antigen R (HuR) expression in hypertension: downregulation of the mRNA stabilizing protein HuR in genetic hypertension","volume":"45","author":"Kl\u00f6ss","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2025.117384_b0620","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159179","article-title":"MicroRNAs as therapeutic targets in cardiovascular disease","volume":"132","author":"Laggerbauer","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117384_b0625","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1242\/jcs.113381","article-title":"Hypoxia induces downregulation of soluble guanylyl cyclase \u03b21 by miR-34c-5p","volume":"125","author":"Xu","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0630","first-page":"1","article-title":"NF-\u03baB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase","volume":"51","author":"Park","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2025.117384_b0635","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.121.053889","article-title":"Metabolic syndrome mediates ROS-miR-193b-NFYA-dependent downregulation of soluble Guanylate Cyclase and contributes to exercise-induced pulmonary hypertension in heart failure with preserved ejection fraction","volume":"144","author":"Satoh","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.117384_b0640","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JAD-190743","article-title":"Post-transcriptional regulation of soluble guanylate cyclase that governs neuropathic pain in Alzheimer's Disease","volume":"71","author":"Xu","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bcp.2025.117384_b0645","doi-asserted-by":"crossref","first-page":"L569","DOI":"10.1152\/ajplung.00401.2012","article-title":"Soluble guanylate cyclase modulates alveolarization in the newborn lung","volume":"305","author":"Bachiller","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bcp.2025.117384_b0650","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41420-023-01560-5","article-title":"Research progress on post-translational modification of proteins and cardiovascular diseases","volume":"9","author":"Cheng","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bcp.2025.117384_b0655","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.celrep.2014.07.036","article-title":"Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser\/Thr-based signaling","volume":"8","author":"Sharma","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2025.117384_b0660","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"534","author":"Mertins","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117384_b0665","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41594-018-0084-y","article-title":"UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites","volume":"25","author":"Akimov","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0670","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1074\/mcp.M900550-MCP200","article-title":"Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists","volume":"9","author":"Christensen","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bcp.2025.117384_b0675","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1074\/mcp.O112.027094","article-title":"Refined preparation and use of anti-diglycine remnant (K-\u03b5-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments","volume":"12","author":"Udeshi","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bcp.2025.117384_b0680","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1538-7836.2008.03014.x","article-title":"NO-synthase-\/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity","volume":"6","author":"Gambaryan","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcp.2025.117384_b0685","doi-asserted-by":"crossref","first-page":"33149","DOI":"10.1074\/jbc.M507565200","article-title":"Reactive oxygen species induce tyrosine phosphorylation of and Src kinase recruitment to NO-sensitive guanylyl cyclase","volume":"280","author":"Meurer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0690","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/ATVBAHA.108.165043","article-title":"Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity","volume":"28","author":"Zhou","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0695","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01751808","article-title":"On the cysteine and cystine content of proteins. differences between intracellular and extracellular proteins","volume":"10","author":"Fahey","year":"1977","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.bcp.2025.117384_b0700","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1074\/jbc.M809460200","article-title":"Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells","volume":"284","author":"Maron","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0705","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cvr\/cvr016","article-title":"Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide","volume":"90","author":"Zheng","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0710","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1073\/pnas.0703944104","article-title":"Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation","volume":"104","author":"Sayed","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113846","article-title":"The heat shock response and small molecule regulators","volume":"226","author":"Kurop","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0720","doi-asserted-by":"crossref","first-page":"12998","DOI":"10.1073\/pnas.1205854109","article-title":"Soluble guanylyl cyclase requires heat shock protein 90 for heme insertion during maturation of the NO-active enzyme","volume":"109","author":"Ghosh","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0725","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1074\/jbc.M411545200","article-title":"Characterization of a novel type of endogenous activator of soluble guanylyl cyclase","volume":"280","author":"Balashova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0730","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00438-023-01992-9","article-title":"Role of c-Src and reactive oxygen species in cardiovascular diseases","volume":"298","author":"Hussain","year":"2023","journal-title":"Mol. Genet. Genomics"},{"key":"10.1016\/j.bcp.2025.117384_b0735","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/jpet.107.132928","article-title":"Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase","volume":"325","author":"Murthy","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117384_b0740","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.106.144501","article-title":"cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology","volume":"100","author":"Zaccolo","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0745","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0898-6568(95)00017-J","article-title":"Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family)","volume":"7","author":"Manganiello","year":"1995","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2025.117384_b0750","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1074\/jbc.272.11.6823","article-title":"Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3)","volume":"272","author":"Degerman","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0755","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.124.21709","article-title":"Cardiac cGMP Regulation and Therapeutic applications","volume":"82","author":"Mishra","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2025.117384_b0760","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1073\/pnas.0906461107","article-title":"Activity of any class IA PI3K isoform can sustain cell proliferation and survival","volume":"107","author":"Foukas","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0765","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/FJC.0000000000000137","article-title":"Cross regulation between cGMP-dependent protein kinase and Akt in vasodilatation of porcine pulmonary artery","volume":"64","author":"Liu","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117384_b0770","doi-asserted-by":"crossref","first-page":"16333","DOI":"10.1074\/jbc.M512378200","article-title":"A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation","volume":"281","author":"Stojanovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0775","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.RES.0000258492.96097.47","article-title":"Mechanisms of vascular smooth muscle cell migration","volume":"100","author":"Gerthoffer","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0780","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s42003-022-03140-2","article-title":"PDGF regulates guanylate cyclase expression and cGMP signaling in vascular smooth muscle","volume":"5","author":"Hildebrand","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0785","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.ATV.0000046231.17365.9D","article-title":"Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator","volume":"23","author":"Yan","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0790","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.HYP.31.1.342","article-title":"Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide","volume":"31","author":"Ichiki","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2025.117384_b0795","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/hc4401.098432","article-title":"Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance","volume":"104","author":"Kim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.117384_b0800","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174200","article-title":"Circularly permuted fluorescent protein-based indicators: history, principles, and classification","volume":"20","author":"Kostyuk","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0805","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnmol.2013.00026","article-title":"Improved genetically-encoded, FlincG-type fluorescent biosensors for neural cGMP imaging","volume":"6","author":"Bhargava","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2025.117384_b0810","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.0710387105","article-title":"Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensors","volume":"105","author":"Nausch","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0815","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/acssensors.6b00582","article-title":"Generation of a cGMP indicator with an expanded dynamic range by optimization of amino acid linkers between a fluorescent protein and PDE5\u03b1","volume":"2","author":"Matsuda","year":"2017","journal-title":"ACS Sens."},{"key":"10.1016\/j.bcp.2025.117384_b0820","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.260591","article-title":"Dynamics of intracellular cGMP during chemotaxis in Dictyostelium cells","volume":"136","author":"Yumura","year":"2023","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2025.117384_b0825","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.celrep.2019.05.102","article-title":"SponGee: a genetic tool for subcellular and cell-specific cGMP manipulation","volume":"27","author":"Ros","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2025.117384_b0830","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1038\/s41467-023-39516-z","article-title":"Subcellular second messenger networks drive distinct repellent-induced axon behaviors","volume":"14","author":"Baudet","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117384_b0835","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1073\/pnas.051631298","article-title":"Spatiotemporal dynamics of guanosine 3',5'-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator","volume":"98","author":"Honda","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0840","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.cellsig.2006.11.012","article-title":"Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells","volume":"19","author":"Cawley","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2025.117384_b0845","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/BJ20070348","article-title":"Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approach","volume":"407","author":"Russwurm","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2025.117384_b0850","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nmeth816","article-title":"Fluorescent sensors for rapid monitoring of intracellular cGMP","volume":"3","author":"Nikolaev","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bcp.2025.117384_b0855","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/cvr\/cvab167","article-title":"CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors","volume":"118","author":"Manfra","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117384_b0860","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s42003-019-0641-x","article-title":"FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons","volume":"2","author":"Calamera","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0865","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1093\/cercor\/bhz041","article-title":"Phosphodiesterase 1 bridges glutamate inputs with NO- and dopamine-induced cyclic nucleotide signals in the striatum","volume":"29","author":"Betolngar","year":"2019","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bcp.2025.117384_b0870","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1085\/jgp.118.1.63","article-title":"In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors","volume":"118","author":"Rich","year":"2001","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bcp.2025.117384_b0875","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/CIRCULATIONAHA.105.599241","article-title":"Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes","volume":"113","author":"Castro","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.117384_b0880","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1038\/ncomms9046","article-title":"Optogenetic manipulation of cGMP in cells and animals by the tightly light-regulated guanylyl-cyclase opsin CyclOp","volume":"6","author":"Gao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117384_b0885","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220058","article-title":"Optogenetic manipulation of cyclic guanosine monophosphate to probe phosphodiesterase activities in megakaryocytes","volume":"12","author":"Zhang","year":"2022","journal-title":"Open Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0890","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.1073\/pnas.1321600111","article-title":"Engineering of a red-light-activated human cAMP\/cGMP-specific phosphodiesterase","volume":"111","author":"Gasser","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117384_b0895","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.jmb.2019.07.011","article-title":"Revisiting and redesigning light-activated cyclic-mononucleotide phosphodiesterases","volume":"431","author":"Stabel","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117384_b0900","doi-asserted-by":"crossref","first-page":"41501","DOI":"10.1074\/jbc.M110.177600","article-title":"Natural and engineered photoactivated nucleotidyl cyclases for optogenetic applications","volume":"285","author":"Ryu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117384_b0905","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1479360","article-title":"Optogenetic elevation of postsynaptic cGMP in the hippocampal dentate gyrus enhances LTP and modifies mouse behaviors","volume":"17","author":"Borovac","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2025.117384_b0910","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cardiores.2007.06.002","article-title":"Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation","volume":"76","author":"Nimmegeers","year":"2007","journal-title":"Cardiovasc. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:29:10Z","timestamp":1769477350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":182,"alternative-id":["S0006295225006495"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117384","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue-specific regulation of NO-GC isoforms in the cardiovascular system","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117384"}}